Improved syntheses of P2X7 ligands based on substituted benzyl amide of pyroglutamic acid motif labelled with iodine-123 or iodine-125

[1]  Hongjun Jin,et al.  Hetero-aryl bromide precursor fluorine-18 radiosynthesis and preclinical evaluation of a novel positron emission tomography (PET) tracer [18F]GSK1482160. , 2022, Bioorganic & medicinal chemistry.

[2]  Q. Zheng.  Radioligands targeting purinergic P2X7 receptor. , 2020, Bioorganic & medicinal chemistry letters.

[3]  T. Chan-Ling,et al.  P2X7 receptor signaling during adult hippocampal neurogenesis , 2019, Neural regeneration research.

[4]  G. Hutchins,et al.  Synthesis and in vitro biological evaluation of new P2X7R radioligands [11C]halo-GSK1482160 analogs. , 2019, Bioorganic & medicinal chemistry letters.

[5]  G. Hutchins,et al.  Synthesis and initial in vitro characterization of a new P2X7R radioligand [18F]IUR-1602. , 2019, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[6]  G. Hutchins,et al.  Synthesis and preliminary biological evaluation of a novel P2X7R radioligand [18F]IUR-1601. , 2018, Bioorganic & medicinal chemistry letters.

[7]  Shane M. Wilkinson,et al.  Identification of the allosteric P2X7 receptor antagonist [11C]SMW139 as a PET tracer of microglial activation , 2018, Scientific Reports.

[8]  Lanfang Li,et al.  The P2X7 purinergic receptor: An emerging therapeutic target in cardiovascular diseases. , 2018, Clinica chimica acta; international journal of clinical chemistry.

[9]  J. Perlmutter,et al.  Synthesis and in vitro characterization of a P2X7 radioligand [123I]TZ6019 and its response to neuroinflammation in a mouse model of Alzheimer disease , 2018, European journal of pharmacology.

[10]  J. Perlmutter,et al.  Pharmacologic characterizations of a P2X7 receptor-specific radioligand, [11C]GSK1482160 for neuroinflammatory response , 2017, Nuclear medicine communications.

[11]  G. Hutchins,et al.  Characterization of 11C-GSK1482160 for Targeting the P2X7 Receptor as a Biomarker for Neuroinflammation , 2017, The Journal of Nuclear Medicine.

[12]  P. Bonaventure,et al.  A novel radioligand for the ATP-gated ion channel P2X7: [3H] JNJ-54232334. , 2015, European journal of pharmacology.

[13]  G. Hutchins,et al.  Synthesis of [(11)C]GSK1482160 as a new PET agent for targeting P2X(7) receptor. , 2015, Bioorganic & medicinal chemistry letters.

[14]  F. Di Virgilio,et al.  Expression of P2X7 receptor increases in vivo tumor growth. , 2012, Cancer research.

[15]  J. Lever,et al.  Synthesis, radioiodination and in vitro and in vivo sigma receptor studies of N-1-allyl-N´-4-phenethylpiperazine analogs. , 2012, Nuclear medicine and biology.

[16]  W. Denny,et al.  Synthesis and Structure−Activity Relationships of Aza- and Diazabiphenyl Analogues of the Antitubercular Drug (6S)-2-Nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824) , 2010 .

[17]  S. Sugama,et al.  P2X7 Receptor Signaling Pathway as a Therapeutic Target for Neurodegenerative Diseases , 2010, Archivum Immunologiae et Therapiae Experimentalis.

[18]  Paul Cumming,et al.  Up‐regulation of PK11195 binding in areas of axonal degeneration coincides with early microglial activation in mouse brain , 2006, The European journal of neuroscience.

[19]  M. Kuhar.  In vitro autoradiography. , 2001, Current protocols in pharmacology.

[20]  A. Fischman,et al.  Preparation and biological evaluation of iodine-125-IACFT: a selective SPECT agent for imaging dopamine transporter sites. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[21]  E. Kawashima,et al.  The Cytolytic P2Z Receptor for Extracellular ATP Identified as a P2X Receptor (P2X7) , 1996, Science.

[22]  J. Lever,et al.  Ether modifications to 1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazine (SA4503): effects on binding affinity and selectivity for sigma receptors and monoamine transporters. , 2015, Bioorganic & medicinal chemistry.

[23]  P. Bonaventure,et al.  Neuropharmacology and analgesia A novel radioligand for the ATP-gated ion channel P 2 X 7 : [ 3 H ] JNJ-54232334 , 2015 .

[24]  H. Wagner,et al.  In vitro and in vivo binding of (E)- and (Z)-N-(iodoallyl)spiperone to dopamine D2 and serotonin 5-HT2 neuroreceptors. , 1990, Life sciences.